[(90)Yttrium-DOTA]-TOC response is associated with survival benefit in iodine-refractory thyroid cancer: long-term results of a phase 2 clinical trial
| Image |  |
|---|---|
| Description | scientific article published in May 2009 |
| Author/s |
author: Martin Walter |
| Publication date | May 1, 2009 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |